Rhoen Klinikum AG (RHK) Receives €24.10 Consensus PT from Analysts
Shares of Rhoen Klinikum AG (ETR:RHK) have received a consensus recommendation of “Hold” from the eleven analysts that are covering the stock, Marketbeat Ratings reports. Five research analysts have rated the stock with a sell rating and six have issued a hold rating on the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is €24.10 ($28.02).
Several research analysts have recently commented on the company. Berenberg Bank set a €27.75 ($32.27) price target on Rhoen Klinikum and gave the stock a “neutral” rating in a research report on Monday, August 6th. Kepler Capital Markets set a €22.00 ($25.58) price target on Rhoen Klinikum and gave the stock a “sell” rating in a research report on Thursday, August 2nd. Warburg Research set a €25.20 ($29.30) target price on Rhoen Klinikum and gave the company a “neutral” rating in a report on Thursday, August 2nd. Cfra set a €25.00 ($29.07) target price on Rhoen Klinikum and gave the company a “sell” rating in a report on Friday, August 3rd. Finally, Independent Research set a €26.00 ($30.23) target price on Rhoen Klinikum and gave the company a “neutral” rating in a report on Wednesday, August 8th.
Shares of RHK traded up €0.20 ($0.23) during midday trading on Friday, hitting €21.96 ($25.53). 24,489 shares of the stock were exchanged, compared to its average volume of 43,281. Rhoen Klinikum has a 52-week low of €25.08 ($29.16) and a 52-week high of €32.12 ($37.35).
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurological disorders, oncology, pneumology, orthopedic, accident, and surgeries; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.
Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.